GDRX - GoodRx Holdings, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 7.71

Open

Bid

$ 7.70 x 700

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 4.14 - $ 9.26

Volume

779,186

Average Volume

Market Cap

2.93B

Beta (5Y Monthly)

$ 1.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-12-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

GoodRx Holdings Stock: A Deep Dive Into An...
08/16/2024 16:01:00

RBC Capital Reiterates Outperform on GoodR...
08/16/2024 15:10:21

RBC Capital analyst Sean Dodge reiterates GoodRx Holdings (NASDAQ:GDRX) with a Outperform and maintains $10 price target.

Citigroup Maintains Buy on GoodRx Holdings...
08/09/2024 22:45:54

Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers the price target from $11 ...

UBS Maintains Neutral on GoodRx Holdings, ...
08/09/2024 15:04:06

UBS analyst Eric Sheridan maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $9 to $8.5.

GoodRx Reports Q2 Earnings With Increased ...
08/08/2024 16:04:38

GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Mo...

GoodRx FY24 Revenue Outlook Lower End Of P...
08/08/2024 10:10:03

Guidance For the third quarter and full year 2024, management is anticipating the following: $ in millions ...

GoodRx Q3 Revenue Outlook $193M-$197M Vs, ...
08/08/2024 10:08:20

Guidance For the third quarter and full year 2024, management is anticipating the following: $ in millions ...

GoodRx Holdings Q2 2024 Adj. EPS $0.08 Mis...
08/08/2024 10:06:28

GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0....

Boehringer Ingelheim and GoodRx Team Up to...
07/18/2024 10:03:46

Boehringer Ingelheim and GoodRx (NASDAQ:GDRX), the leading prescription savings platform in the U.S., announced today a patien...

microstrategy-coinbase-robinhood-tesla-and-other-big-stocks-moving-higher-on-monday

MicroStrategy, Coinbase, Robinhood, Tesla ...
07/15/2024 15:04:09

GoodRx Debuts Prescription Cost Tracker; A...
06/26/2024 13:17:30

Reveals Consumers Paid $21B Out-of-Pocket in 2024, Averaging $16.26 Per Prescription

The Analyst Landscape: 7 Takes On GoodRx H...
06/10/2024 12:01:09

Morgan Stanley Maintains Equal-Weight on G...
06/10/2024 09:35:09

Morgan Stanley analyst Craig Hettenbach maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weight and raises the price tar...

GoodRx Strengthens Core Business With New ...
05/23/2024 16:38:55

GoodRx has been upgraded by RBC Capital Markets due to the growth potential from the Integrated Savings Program, direct contrac...

RBC Capital Upgrades GoodRx Holdings to Ou...
05/23/2024 09:46:34

RBC Capital analyst Mark Mahaney upgrades GoodRx Holdings (NASDAQ:GDRX) from Sector Perform to Outperform and raises the pri...

Barclays Maintains Overweight on GoodRx Ho...
05/20/2024 14:06:37

Barclays analyst Stephanie Davis maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and raises the price target from ...

Raymond James Upgrades GoodRx Holdings to ...
05/16/2024 17:04:41

Raymond James analyst John Ransom upgrades GoodRx Holdings (NASDAQ:GDRX) from Market Perform to Outperform and announces $10...

Forecasting The Future: 13 Analyst Project...
05/16/2024 16:00:47

TD Cowen Maintains Buy on GoodRx Holdings,...
05/16/2024 14:27:14

TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $14 to $16.

goodrx-shares-soar-nearly-10-as-new-partnership-with-kroger-promises-big-savings

GoodRx Shares Soar Nearly 10% As New Partn...
05/15/2024 18:40:57

GoodRX shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroge...